Supercharging Immunotherapy

News

HOOKIPA Pharma to Present at Kempen Life Science Conference

HOOKIPA announces positive preliminary Phase 1 immunogenicity data for its…

For more information follow the links to our PR and the Poster Presentation

HOOKIPA Reports Fourth Quarter and Full Year 2020 Financial Results and…

HOOKIPA Pharma To Report Fourth Quarter and Full Year 2020 Financial Results…

Pre-clinical data on HOOKIPA’s alternating 2-vector cancer therapeutics …

Publication underscores the potential of our arenavirus platform as a new class of cancer immunotherapeutics.

HOOKIPA Pharma to Participate in Upcoming H.C. Wainwright Global Life…

The conference is being conducted in a virtual format and a webcast of the presentation will become available on Tuesday, March 09, 2021 at 7:00 AM ET